Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YAY ALMOST DONE > Lecture 10: Sympathetic NS > Flashcards

Lecture 10: Sympathetic NS Flashcards

1
Q

How does NE effect the CV system?

A
  • overall vasoconstriction (increase in TPR)
  • increased strength of vasoconstriction (ionotropy)
  • initially HR goes up (chronotropy) but drops back down due to baroreceptor reflex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What would be used to delay premature contractions?

A

epinephrine: decreases smooth muscle tone so it can’t contract as well

salbutamol: B2 agonist that relaxes uterine smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phenylephrine (PE), an a1 Ag are used in cold remedies because?

A
  • during colds, there is vasodilation causing fluids to lead causing congestion
  • a1 agonist causes vasoconstriction in upper respiratory mucosa to stop congestion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phenylepherine (half life and potency)

A
  • selective a1 agonist
  • longer t1/2 than NE because not broken down by COMT, but less potent than NE
  • can activate B2 R at high doses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phenylepherine clinical use

A

selective a1 agonist

CV: increases BP
- causes reflex bradycardia, so used to treat atrial bradycardia
- in hypotensive states (people who are hypertensive should not use this)

decongestant and anti-allergy
- causes constriction
- but desensitization with repeated dosing

dilation (myadratic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clonidine use

A

selective a2 R agonist (mainly on N terminals)

treats hypertension
- decreases BP, bradycardia, and CO due to blocking NE release from nerve terminals
- centrally blocks excitatory outflow
- peripherally presynaptic inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clonidine ADR

A

adverse effects
- decreased TPR with chronic admin
- rebound hypertensive crisis with sudden withdrawal
- dry mouth and constipation (targets a2 on parasympaethic terminals too), bradycardia,
and sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Apraclonidine

A

more seletive than clonidine

use as adjust glaucoma treatment because it is very local (reduces production of aqueous humour and decreasing IOP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Isoproterenol

A

non-selective B agonist
- no therapeutic use
- most potent B agonist with longer t1/2
- severe cardiac side effects: peripheral vasodilation, tachycardia, myocardial stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dobutamine

A

selective B1 agonist
- synthetic DA derivative
- positive ionotropic effect greater than chronotropic effect
- increases SV at low dose and no change in HR –> increases CO
- used short term treatment of HF, acute MI, and heart surgery (long term would cause death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are selective B2 R agonists used to treat?

A

primarily asthma without stimulating B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Salbutamol (albuterol)

A

selective B2 R agonist

bronchodilation
- B2 on bronchiole sm
- skeletal muscle vasodilation to decrease TPR
- high dose could stimulate CV effects

delay premature labour
- relaxes uterus sm so there are no contractions

duration and t1/2 can be extended with newer agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Salmeterol

A

selective B2 agonist
- anchors to R for extended action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Terbutaline

A

selective B2 agonist

used to delay premature labour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mirabegron

A

selective B3 agonist
- treats overactive bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indirect acting sympathomimetics can act by

A
  • increase synthesis
  • stimulate release
  • inhibit presynaptic transporter for reuptake to increase NT in cleft –> cocaine (DAT), desimimpramine/amytriptyline (NET), amphetamine
  • inhibit degredation by enzymes –> MAO-A I: clorgyline, MAO-B I: selegiline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why should we be cautious when eating foods with tyramine (cheese)?

A
  • VMAT substrate with no direct effect
  • when used with MAOIs –> this prevents degrdation and increases NE displacement causing a sudden increase in BP
  • can lead to hypertensive crisis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ephedrine

A

mixed action sympathomimetic
- both NE release and direct a1, B1, B2 R binding
- orally effective prolonged action stimulant
- increases heart rate, bronchodilation and skeletal muscle tone
- less potent vasopressor than EPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pseudoephedrine

A

mixed action sympathomimetic
- isomer of ephedrine
- a1, b2 R agonist
- decongestant, stimulant
- however can be used to make methamphetamine

20
Q

Phenoxybenzamine

A

non selective a R ANT (at a2 will block synaptic feedback –> increase NT release)
- irreversible (dose response curve shifts right)
- decreasing but persistant block 3 days after exposure

results
CV: decreases TPR, DR, and causes tachycardia (baroreceptores aren’t active so NE release into the heart increases HR)
- hypotensive response greater in HT patients
- used to treat pheochromocytoma

metabolic
- insulin secretion (unmasking B2 effects and no alpha inhibition of insulin release –> hypoglycemia), lipolysis

21
Q

Phentolamine

A

non selective alpha R ANT

  • reversible and competitive inhibition
  • slightly higher affinity for a1 –> increases SP but also triggers baro reflex and blocks a2 autoreceptors
  • cv effects same as phenoxybenzamine but transient

use
- short term HT treatment
- pheochromocytoma
- tyramine rich diets in pateinst atking MAOI

22
Q

Prazosin

A

selective a1 R ANT

used for mild-moderate HT, CHF

  • decrease in TPR, DP, VR, pre and after load, pulmonary congestion
  • increase in CO
  • tachycardia via baroR can occur –> decrease in TPR increases symp. outflow to heart but is not due to autoinhibition via a2 (bc this is a1 selective)
  • first dose phenomenon - orthostatic hypotension
23
Q

Tamsulosin

A

selective alpha 1 R ANT

used to treat
- mild/moderate HT and benign prostatic hyperplasia (BPH - a1A overexpression)
- high affinity for a1A and a1D subtypes (70% alpha R are a1A in prostate and sphincter of bladder)

24
Q

Yohimbine

A

selective a2 ANT
(not used because it inhibits autoreceptors)

low dose: reversible competitive a2 ANT
- stimulates NE release
- increases BP, HR, tremor, excitation, ADH release
- blocks clonidine peripheral CV/motor effects

high doses: blocks a1 R
- causes transient decrease in BP and binds to 5HT R

used to be for treating male sexual dysfunction but rplaced by PDE inhibitors

25
Q

Nadolol

A

non selective B R ANT
- longest acting: t1/2 = 14-24 hours
- slow absorption
- used as prophylaxis for angina

26
Q

Pindolol

A

non selective B R ANT
- acts as partial agonist –> in the absence of catecholamines it maintains signalling but in excess it will block beta R
- can be used in bradycardia or low cardiac reserve

27
Q

Timolol

A

non selective beta R antagonist
- similar t1/2 as propranolol (4 hours) but less potent
- clinical use in glaucoma to decrease IOP

28
Q

Propranolol

A

non selecting beta R antagonist

absorbed from GI, t1/2 =4 hours

CV therapeutic effects
- negative chronotropic effects = bradycardia (HT or normotesnive during exercise)
- negative ionotropic effect, decreased CO, decreased O2 use, decreased ACE
- unbalanced vagal tone: slowed pacemaker activity, decreased AV conduction
- increased TPR via alpha R activation but overall hypotension with chronic use

29
Q

Propranolol effects in a normotensive individual

A
  • efficacy depends on sympathetic tone –> won’t do anything to a normal person btut will have an effect on someone who is hypernsive since they have a lot of NE
30
Q

Propranolol unwanted effects

A

bronchiolar smooth muscle
- bronchospasm and airway resistance increased due to block of B2
- not ideal for asthma

metabolic effects
- inhibit insulin secretion via B2 block
- block hyperglycemic response to EPI
–> alpha2 activity increases blood glucose –> can induce hypoglycemia after exercise or insulin admin if there are no glucagon stores
- can mask hypoglycemic symptoms such as increase in HR so people don’t know they’re hypoglycemic
- need to be used with caution in diabetics

predictable, widespread, and diffuse effects
- severe bradycardia, CHF, bronchoconstriction
- hypoglycemia
- aggravation of peripheral artery disease (PAD) due to unopposed alpha R activation

CV effects
- with abrupt withdrawal

31
Q

Metoprolol/Atenolol

A

selective B1 R ANT (cardioselective)
- similar activity as propranolol at B1 but less at B2
- prophylaxis of angina, HT, heart failure

32
Q

Esmolol

A

selective B1 R Antagonist
short acting - rapidly hydrolyzed by esterases in blood cells

33
Q

Betaxolol

A

used to treat glaucoma
- opthalmic prep alone or with muscarinic (pilocarpine) to decrease IOP

34
Q

Labetolol

A

mixed action beta ANT (3rd gen)

ANT at B1 and a1 (3:1 ratio of antagonist)

partial AG at B2 - won’t block diastolic pressure drop so won’t cause reflexive tachycardia

decrease in BP without reflex tachycardia and increase in CO

35
Q

Carvedilol

A

mixed action beta antagonist

ANT at a1 and B with 10x higher affinity for B
- reduce TPR and improve LV ejection fraction

36
Q

Cimetidine interaction with beta blockers

A

CIMETIDINE (antihistamine) inhibits CYP associated with metabolism of PROPRANOLOL, METOPROLOL, LABETALOL
- increases their bioavailability and plasma concentration

37
Q

What is the effect of Beta Adr R ANT on insulin effects?

A

insulin hypoglycemic effects enhanced/prolonged

can mask hypoglycemia

38
Q

Beta blocker paradoxical pharmacology in CHF and asthma

A
  1. congestive heart failure
    Beta R agonist
    - acute: beneficial (increases contractility)
    - chronic: detrimental
    Beta R antagonist
    - acute: detrimental (decreases contractility_
    - chronic: beneficial (increases contractility and decreases mortality)
  2. asthma
    Beta R AG
    - acute: beneficial (bronchodilation)
    - chronic: detrimental
    Beta R ANT
    - acute: detrimental (bronchoconstriction)
    - chronic: ALSO DETRIMENTAL
39
Q

Reserpine MOA

A

indierect ADR ANT

binds to VMAT –> blocks transport of NE/DA into vesicles –> NE leaks into cytoplasm and is degraded by MAO –> decreases abilty to store NE so there is no NT release when an action potential happens

chronic treatment - R upregulation
- increases sensitivity to catecholamines –> sympathomimemtic effects
- abolishes response to indirect acting sympathomimetics

used for Ht with hydrocholothiazide

40
Q

Reserpine clinical CV effects and ADR

A

CV effects
- decreased NE in peripheral synaptic terminals –> decreases stimulation of a1 R –> decreased S tone and PS is dominant tone
- decreased HR, BP, CO
- effects additive with hypertensive agents

Adverse effects
PS tone dominant
- bradycardia, postural hypotension
- NA and fluid retention
- increased GI tone and decreased –> increased motility and diarrhea
- increased nasal congestion and respiratory issues
CNS
- Parkinsonism, lethargy,s edation, depression
- increse breast gancer, galatorrhea

41
Q

effects of reserpine on tyramine and amphetamine

A

reduces their effects
- tyramine: precursor to catecholamines –> res leads to their degredation
- amphetamine: increased DA/NE in synapse –> res prevents them from being released into the synapse

42
Q

Guanethidine

A

indirectly acting ADR ANT
- competes for NAT with NE –> transported into peripheral nerve endings and accumulated in vesicles
- gradual depletion of NR from vesicle stores
- chronic use leads to supersensitivity and potebtiates exogenous NE and sensitizes effector cells to catecholamines
- effects of indirect sympathomimetics are reduced
- blocks amine uptake and vesicle NE release after MOA degredation

false transmitter –> cocaine, TCAs interefere competitively with uptake of guanethidine

43
Q

alpha-methyldopa/alpha-methyl NE

A

indirectly acting ADR ANT
- false transmitter
- substrate for dopa decarboxylase in vesicles
- released upon nerve stimulation

44
Q

alpha-methyltyrosine

A

indirectly acting ADR ANT
- inhibits biosynthesis of catecholamines centrally, periphearally, and in adrenal medulla
- competitive inhibitor of tyrosine hydroxylase

clinical CV effects
- decreased HR and BP
- greater response in hyperstention: decreased TPR and CO
- reduced SYMP tone

45
Q

Clonidine’s indirect ADR ANT action

A
  • both sympathomimemtic and sympatholytic
  • binds to a2 autoreceptor and inhibits NE release
  • in medulla oblongata: blunts sympathetic tone
  • peripherally: decreases NE release form axon terminal

use
- prophylactic for migraine
- alleviate alcohol and opioid withdrawal

ADR
- dry mouth, constipatoin, sedation, bradycardia
- rebound HT with sudden withdrawal
- TCA, desmethylimipramine, phenothiziane interfers with CV anti hypertensive effects

YAY ALMOST DONE (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions